Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorScientific Institute San Raffaele

About this trial

The study is a retrospective, observational and multicentric study. The study describes robotic segmentectomies performed in four referred centers, with the aim to assess the perioperative compilications of robotic segmentectomies compared to video-assisted thoracoscopic surgery (VATS) and open approach.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pre or post-operative diagnosis of NSCLC surgically treated with pulmonary segmentectomy from 1st January 2010 to the 31st to December 2023.

Age > then 18 years at the moment of surgery

Disqualifiers

Age < then 18 years at the moment of surgery

diagnosis other than NSCLC

Trial population

Patients that underwent segmentectomies from the 1st January 2010 to the 31st of December 2023 treated with robotic segmentectomy (case) and video-assisted thoracoscopic (VATS) or open segmentectomy (control)

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

472 Participants
are grouped into 2 trial groups
Group A: Case group : Robotic Approach
Group B: Control group: video-assisted thoracoscopic surgery (VATS) and open

Trial outcomes

Primary outcomes

1

The perioperative complications of robotic approach

The investigators will measure the perioperative complications of robotic lung resection in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.

Time frame
from the surgery at 30-90 days after
2

The perioperative complication of video-assisted thoracoscopic surgery (VATS) approach

The investigators will measure the perioperative complications of video-assisted thoracoscopic surgery (VATS) appraoch in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.

Time frame
30-90 days after surgery
3

The perioperative complications of the open approach

The investigators will measure the perioperative complications of open approach in patients with a pre or post-operative diagnosis of non-small cell lung cancer (NSCLC). Complications will be categorized according to the Clavien-Dindo scale.

Time frame
30-90 days after surgery

Secondary outcomes

1

Duration of surgery

Duration of the surgery based on the approach measured in minutes

Time frame
up to 1 month
2

Quality of lymphadenectomy

Number of lymphonodes station resected

Time frame
up to 1 month
3

Conversion rate

Number of surgery procedures converted

Time frame
up to 1 month
4

Survival analysis

Presence or absence of local and distant relapse

Time frame
up to 5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Scientific Institute San Raffaele

Lead sponsor

Istituto Clinico Humanitas

Collaborator

Istituto Europeo di Oncologia

Collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborator